Brind.
  1. Veracyte and Transmedics operate within the same molecular diagnostic industry.

The removal of Triumph Group impacted market sentiment on July 26, 2025, affecting companies like Veracyte.

1 report, 1 independent Updated Jul 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

The removal of Triumph Group impacted market sentiment on July 26, 2025, affecting companies like Veracyte.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Triumph Group was replaced in the index on July 25, 2025, while Veracyte joined, amid acquisition plans by Warburg Pincus and Berkshire Partners.Sub-event
  2. Triumph Group removal impacted market sentiment affecting companies in the molecular diagnostic industry.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Insider MonkeyVeracyte (VCYT) Soars 7% on S&P SmallCap 600 Inclusion We recently published 10 Shares Explode as Earnings Impress. Veracyte, Inc. (NASDAQ:VCYT) is one of the best-performing stocks on Friday. Veracy